Tahir Misbah 4
4 · Maze Therapeutics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Tahir Misbah
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-03-02+40,000→ 40,000 totalExercise: $45.61Exp: 2036-03-01→ Common Stock (40,000 underlying) - Award
Restricted Stock Units
[F2][F3][F4]2026-03-02+20,000→ 20,000 total→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F3]The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F4]These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
Signature
/s/ Courtney Phillips, as attorney-in-fact|2026-03-03